{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:49Z","timestamp":1753891249165,"version":"3.41.2"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Systemic amyloidosis is a rare protein misfolding and deposition disorder leading to progressive organ failure. Waldenstr\u00f6m macroglobulinemia (WM) with systemic amyloidosis as the main manifestation is even rarer. The patient in this study presented with recurrent diarrhea and had not been diagnosed in other hospitals on multiple occasions. Later, his diarrhea worsened and was accompanied by sunken edema of both lower limbs and dizziness. Renal biopsy showed deposits of PAS light-staining material in the glomeruli, interstitium, and small arteries, which stained positively with Congo red. Cardiac ultrasound showed interventricular septum thickening of 17\u2009mm, right ventricular wall myocardial thickening of approximately 0.6\u2009cm, and septal thickening of approximately 0.5\u2009cm, considering myocardial amyloidosis. Electromyography showed abnormal peripheral nerve conduction. Lymphoplasmacytic cells were found in the bone marrow. Taken together, he was diagnosed with WM. He was treated with a BR (Bendamustine + Rituximab) regimen. After 6 courses, the patient\u2019s discomfort was relieved, his weight gained 5\u2009kg, the level of serum IgM and dFLC decreased, and cardiac and renal assessments were more relieved. The patient has been followed up for more than 1\u2009month.<\/jats:p>","DOI":"10.3389\/fmed.2024.1340553","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T04:42:40Z","timestamp":1713501760000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: Waldenstrom macroglobulinemia with systemic amyloidosis as the main manifestation"],"prefix":"10.3389","volume":"11","author":[{"given":"Junjing","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1053\/j.seminhematol.2023.03.008","article-title":"The epidemiology of Waldenstr\u00f6m macroglobulinemia","volume":"60","author":"McMaster","year":"2023","journal-title":"Semin Hematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1200\/jco.19.02314","article-title":"Genomic landscape of Waldenstr\u00f6m Macroglobulinemia and its impact on treatment strategies","volume":"38","author":"Treon","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ajh.26796","article-title":"Waldenstr\u00f6m macroglobulinemia: 2023 update on diagnosis, risk stratification, and management","volume":"98","author":"Gertz","year":"2023","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40265-022-01830-z","article-title":"Diagnosis and treatment of AL amyloidosis","volume":"83","author":"Palladini","year":"2023","journal-title":"Drugs"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1016\/s2352-3026(20)30224-6","article-title":"Consensus treatment recommendations from the tenth international workshop for Waldenstr\u00f6m Macroglobulinaemia","volume":"7","author":"Castillo","year":"2020","journal-title":"Lancet Haematol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/bjh.18036","article-title":"Diagnosis and management of Waldenstr\u00f6m macroglobulinaemia\u2014a British Society for Haematology guideline","volume":"197","author":"Pratt","year":"2022","journal-title":"Br J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"ITC177","DOI":"10.7326\/aitc202212200","article-title":"Monoclonal Gammopathy of undetermined significance","volume":"175","author":"Gonsalves","year":"2022","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"103926","DOI":"10.1016\/j.critrevonc.2023.103926","article-title":"Monoclonal gammopathy of renal significance: multidisciplinary approach to diagnosis and treatment","volume":"183","author":"Karam","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/bjh.12286","article-title":"Systemic amyloidosis in England: an epidemiological study","volume":"161","author":"Pinney","year":"2013","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.3390\/ijms24054655","article-title":"Diagnostic challenges and solutions in systemic amyloidosis","volume":"24","author":"Goldis","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.3324\/haematol.2020.262899","article-title":"A prognostic index predicting survival in transformed Waldenstr\u00f6m macroglobulinemia","volume":"106","author":"Durot","year":"2021","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1038\/s41375-019-0431-y","article-title":"A revised international prognostic score system for Waldenstr\u00f6m's macroglobulinemia","volume":"33","author":"Kastritis","year":"2019","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1200\/jco.22.00495","article-title":"Waldenstrom Macroglobulinemia: tailoring therapy for the individual","volume":"40","author":"Gertz","year":"2022","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05345-9","article-title":"Waldenstr\u00f6m macroglobulinemia: a review of pathogenesis, current treatment, and future prospects","author":"Ghafoor","year":"2023","journal-title":"Ann Hematol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1340553\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T04:42:43Z","timestamp":1713501763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1340553\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":14,"alternative-id":["10.3389\/fmed.2024.1340553"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1340553","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2024,4,19]]},"article-number":"1340553"}}